By Sheeba M. | Weedstock Market Intelligence | Saturday, October 3, 2026
Cannabis investors head into the weekend with a cautiously constructive setup as Q4 catalysts accumulate. With the DEA rescheduling process entering its most consequential phase and major MSOs approaching key earnings windows, the October 3 pre-market picture deserves close attention before Monday’s open.
Saturday Pre-Market Snapshot
While U.S. equity markets are closed Saturday, over-the-counter cannabis names including CURLF, GTBIF, and VRNOF trade on Canadian exchanges that were active Friday. The broader cannabis sector closed out the week with mixed signals — institutional positioning remains cautious ahead of the DEA final rule, but retail sentiment has turned more optimistic as the October regulatory calendar fills in.
CURLF (Curaleaf Holdings) remains the most-watched bellwether. After a volatile September, shares are consolidating near key support levels. Management’s Q4 guidance assumes continued Florida and New York market share gains. Any weekend DEA headlines could catalyze a gap move Monday morning.
GTBIF (Green Thumb Industries) continues to trade at a premium to sector peers, reflecting its Illinois-heavy revenue mix and cleaner balance sheet. GTI’s recent Illinois store expansions are showing early contribution, and Q3 results — expected mid-October — are tracking ahead of Street consensus per channel checks.
DEA Weekend Catalyst Watch
The DEA rescheduling process remains the single highest-impact catalyst for cannabis equities through year-end. A formal Schedule III final rule would immediately:
- Eliminate 280E federal tax treatment for cannabis operators
- Unlock banking access via SAFE Banking pathway
- Trigger significant institutional reallocation into cannabis equities
- Accelerate MSOS ETF inflows from currently restricted accounts
Multiple congressional staffers have confirmed that bipartisan pressure on DEA to accelerate the final rule timeline has intensified following Q3 state-level ballot successes.
Q4 Catalyst Roadmap
- Mid-October: Q3 2026 earnings season opens — GTI, Trulieve, Curaleaf expected first
- Late October: Potential DEA final rule Federal Register publication window
- November: Congressional SAFE Banking vote probability increases post-DEA action
- December: Year-end tax-loss selling reversal typically benefits oversold cannabis names
Track cannabis stock movements live on Weedstock’s market tracker.
MSO Positioning Summary
Verano Holdings (VRNOF): Illinois and New Jersey momentum remains strong. Verano’s dispensary-adjacent retail strategy has driven above-average ticket sizes versus peers.
Trulieve (TCNNF): Florida remains 75%+ of revenue — a concentrated risk but also the most defensible market position given Trulieve’s store density advantage.
Cresco Labs (CRLBF): Illinois wholesale leadership provides a floor bid on valuation.
Sheeba’s Weekend Take
The setup heading into Q4 is as constructive as it has been in 18 months. The DEA catalyst is real, the earnings season is approaching, and institutional capital is positioned to re-enter once regulatory clarity arrives. Know your entries, know your thesis, and let the catalysts come to you.
Sheeba M. covers cannabis capital markets for Weedstock. This is not investment advice.